SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Mark Stolar, MD

Associate Professor of Clinical Medicine

Feinberg School of Medicine 

Northwestern University

Chicago, IL

Title
: Using GLP-1 Receptor Agonists: A Better Path For Postprandial Glycemic Control
Activity/Course #:
: NCME306
Cost:
: Free
Release/Start Date:
: Nov 01 2016
Expiration Date:
: Oct 31 2017
Topics:
: Diabetes
Target Audience:
: Primary Care Providers
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:
(Chrome not supported at this time)
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2016 conference. The topic of this webcast is Using GLP-1 Receptor Agonists: A Better Path For Postprandial Glycemic Control and features Mark Stolar, MD.
Learning Objective(s):
After completing this program participants should be able to:
  1. Recognize the role of postprandial hyperglycemia in type 2 diabetes (T2DM) patients not at target and examine its role in the pathogenesis of diabetic complications
  2. Utilize glucagon-like peptide (GLP)-1 receptor agonist (GLP-1 RA) therapy to address post-prandial hyperglycemia in ways current fixed dose strategies do not
  3. Compare GLP-1 RAs for glycemic efficacy and differential impact on postprandial glycemic control
  4. Discuss various GLP-1 RA combination strategies to effectively control fasting and post-prandial hyperglycemia


This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Mark Stolar, MD
, Speaker, has the following relationship to disclose: Speaker/Advisory Board – Takeda, Sanofi, Astra Zeneca.

Richard Beaser, MD, Planning Committee, has no relationships to disclose.

Robert Busch, MD, FACE, Planning Committee, has the following relationship to disclose: Speaker – Astra Zeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk.

Louis Kuritzky, MD, Planning Committee, has the following relationship to disclose: Advisor/Consultant/Speaker –Boehringer Ingelheim, Sanofi Aventis, Salix, AbbVie, Allergan, Lilly, Lundbeck, Novo Nordisk, Janssen.

Jeff Unger, MD, ABFM, FACE, Planning Committee, has the following relationship to disclose: Speaker, Stock Owner, Consultant/Research – Novo Nordisk; Speaker – Janssen, Teva.

Gregg Sherman, MD
, Course Director, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.